Publications
- Huprine Y-Tryptophan heterodimers with potential implication to Alzheimer's disease treatment2021 | Faculty of Pharmacy in Hradec Králové, First Faculty of Medicine
- 2-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer's disease2021 | Publication without faculty affiliation
- Discovery of multifunctional anti-Alzheimer's agents with a unique mechanism of action including inhibition of the enzyme butyrylcholinesterase and gamma-aminobutyric acid transporters2021 | Publication without faculty affiliation
- Discovery of novel berberine derivatives with balanced cholinesterase and prolyl oligopeptidase inhibition profile2020 | Publication without faculty affiliation
- Amyloidní hypotéza2020 | Publication without faculty affiliation
- Těžké kovy v Alzheimerově chorobě, chelátory kovů2020 | Publication without faculty affiliation
- Donepezil derivatives targeting amyloid-beta cascade in Alzheimer's disease2019 | Publication without faculty affiliation
- Newly developed drugs for Alzheimer's disease in relation to energy metabolism, cholinergic and monoaminergic neurotransmission2018 | First Faculty of Medicine
- 2,6-Disubstituted 7-(naphthalen-2-ylmethyl)-7H-purines as a new class of potent antitubercular agents inhibiting DprE12023 | Faculty of Pharmacy in Hradec Králové
- Recent advances in dopamine D-2 receptor ligands in the treatment of neuropsychiatric disorders2023 | Publication without faculty affiliation
Loading network view...